- Conditions
- Rhinitis, Allergic, Perennial, Asthma
- Interventions
- Glycerinated German Cockroach Allergenic Extract, Placebo
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 4
- States / cities
- Denver, Colorado • Chicago, Illinois • Baltimore, Maryland + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 127
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Mometasone Furoate Nasal Spray, 50 mcg, Nasonex Nasal Spray, 50 mcg, Placebo Nasal Spray
- Drug
- Lead sponsor
- Amneal Pharmaceuticals, LLC
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 811 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 10
- States / cities
- Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 2 more
- Conditions
- Asthma
- Interventions
- fluticasone propionate/salmeterol, fluticasone propionate, montelukast
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 15 Years and older
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 80
- States / cities
- Ozark, Alabama • Tempe, Arizona • Little Rock, Arkansas + 67 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Olopatadine HCL Nasal Spray, 0.6%, Fluticasone Propionate Nasal Spray, 50 mcg
- Drug
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 130 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2008
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Allergic Rhinitis, Chronic Urticaria
- Interventions
- Levocetirizine 1.25 mg, Placebo
- Drug · Other
- Lead sponsor
- UCB Pharma
- Industry
- Eligibility
- 6 Months to 11 Months
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 26
- States / cities
- Birmingham, Alabama • Hot Springs, Arkansas • Jonesboro, Arkansas + 23 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- PL nasal spray, fluticasone furoate (FF), PL eye drops, olopatadine (OLO)
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Allergy, Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis
- Interventions
- Not listed
- Lead sponsor
- West Penn Allegheny Health System
- Other
- Eligibility
- 6 Years to 18 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- fluticasone furoate
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- ACT-129968, Placebo, Cetirizine
- Drug
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.
- Industry
- Eligibility
- 12 Years to 76 Years
- Enrollment
- 630 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 7
- States / cities
- Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 1 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Epinastine Nasal Spray
- Drug
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 571 participants
- Timeline
- 2006 – 2007
- U.S. locations
- 7
- States / cities
- Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 2 more
- Conditions
- Rhinitis, Allergic, Seasonal
- Interventions
- PQ Grass, Active Placebo, Standard Placebo
- Biological · Drug
- Lead sponsor
- Allergy Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 119 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 8
- States / cities
- Lexington, Kentucky • White Marsh, Maryland • Ocean Township, New Jersey + 5 more
- Conditions
- Seasonal Allergic Rhinitis, Hay Fever
- Interventions
- Beclomethasone dipropionate, Placebo Nasal Aerosol
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 340 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 4
- States / cities
- Austin, Texas • New Braunfels, Texas • San Antonio, Texas + 1 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray, Placebo nasal spray
- Drug
- Lead sponsor
- Padagis LLC
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 951 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 30
- States / cities
- Stockbridge, Georgia • Louisville, Kentucky • Baltimore, Maryland + 21 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- MP29-02, azelastine Hcl, fluticasone propionate, placebo
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 607 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 7
- States / cities
- Austin, Texas • New Braunfels, Texas • San Antonio, Texas + 1 more
- Conditions
- Allergy
- Interventions
- Grazax
- Drug
- Lead sponsor
- ALK-Abelló A/S
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 329 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Mometasone, Placebo
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 59 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Hay Fever
- Interventions
- topical nasal rEV131
- Drug
- Lead sponsor
- Evolutec Group
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 112 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005
- U.S. locations
- 2
- States / cities
- San Antonio, Texas
- Conditions
- Rhinitis, Allergic, Seasonal
- Interventions
- Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals), Fluticasone furoate (Veramyst®) 27.5 mcg/actuation nasal spray, Placebo
- Drug
- Lead sponsor
- Sandoz
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 727 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 7
- States / cities
- Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 2 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Olopatadine Hydrochloride Nasal Spray 0.6%, Vehicle
- Drug
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 6 Years to 11 Years
- Enrollment
- 2,388 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2007
- U.S. locations
- 1
- States / cities
- Kenilworth, Illinois
- Conditions
- Seasonal Allergic Rhinitis, Hay Fever, Allergic Conjunctivitis, Hypersensitivity
- Interventions
- Bilastine, Placebo
- Drug
- Lead sponsor
- Faes Farma, S.A.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 805 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 13
- States / cities
- Oklahoma City, Oklahoma • Austin, Texas • Kerrville, Texas + 2 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- QNASL, Placebo nasal spray
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Hay Fever, Perennial Allergic Rhinitis
- Interventions
- Ciclesonide
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 2 Years to 5 Years
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 3
- States / cities
- Long Beach, California • Normal, Illinois • San Antonio, Texas
- Conditions
- Influenza Infection
- Interventions
- VRC-FLUNPF099-00-VP (H1ssF_3928)
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Allergic Rhinitis, Chronic Urticaria
- Interventions
- Levocetirizine, Placebo
- Drug
- Lead sponsor
- UCB Pharma
- Industry
- Eligibility
- 2 Years to 6 Years
- Enrollment
- 173 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 28
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Beverly Hills, California + 25 more